Potassium Iodide Sales Surge on Heels of Large Government Order
North Korea, Iran and new 65mg pill also boost stockpiling measures
13 Apr, 2012, 08:20 ET
MOORESVILLE, N.C., April 13, 2012 /PRNewswire/ -- A recent solicitation by the Defense Logistics Agency for 1,050,000 doses of Iosat Potassium Iodide has created a deluge of orders for emergency radiation products supplier Nukepills.com. Slated for troop support, the 130mg tablets provide protection against radioactive iodine in the event of a nuclear crisis. International concerns about the development of nuclear weaponry in Asia and the Middle East have also helped boost sales of the radiation drug to levels not seen in the past decade, except for last year's Fukushima nuclear reactor disaster in Japan. "We've been in business 13 years and have never seen such continued levels of stockpiling of potassium iodide," stated Troy Jones, President of Nukepills.com. "Last year during the Japan crisis we sold our normal 6-month supply of stock within 4 days with most of those orders going to U.S. west coast residents. Now we are trying to keep up with this sustained demand because of North Korea and Iran. Our wholesale orders to other websites, nuclear facilities and medical centers are starting to surpass our retail sales." Many wholesale orders of Iosat are the result of this week's viral news of the U.S. government's request for potassium iodide for its medical chain supply.
Nukepills.com also has a new 65mg Iosat Potassium Iodide tablet to add to its growing arsenal of radiation emergency products. The FDA-approved, half-strength tablet was developed as a safe and effective regimen for children. Though the current 130mg tab is scored and can be easily split for administration to children, the new Iosat-65 tab was created for ease of single unit dosing. Iosat-65 is currently restricted to overseas sales. Nukepills.com is actively seeking international distributors for this newly FDA-approved radiation drug.
Stockpiling of potassium iodide is recommended by health officials worldwide to prevent thyroid cancer of those exposed to radioactive iodine in the event of a nuclear reactor accident or detonation of a nuclear bomb. FDA-approved in 1982, Potassium Iodide is available without a prescription. More information about FDA-approved potassium iodide can be found online at http://www.nukepills.com.
Nukepills.com, celebrating its 13th year in business, is an Internet-based supplier and wholesaler of radiation emergency preparedness products that protect against dirty bomb radiation, nuclear reactor accidents and nuclear weapon fallout, and are used for radiation therapy/decontamination in hospitals. In early 2009, Nukepills.com sold 5.4 million doses of FDA-approved ThyroShield™ Liquid Potassium Iodide to Kuwait's Ministry of Health and expects Government Emergency Preparedness grants and civilian orders to continue to drive sales of all its products well into 2012.
Contact: Troy Jones, President, Nukepills.com
631 Brawley School Rd. STE 407
Mooresville, NC 28117
This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.
Share this article